Connect with us

Australia

THC Global shares surge after securing medicinal cannabis manufacturing license

THC Global Group Ltd (ASX:THC) has secured a licence to manufacture therapeutic goods at its Southport Facility, completing all licenses required to commence commercial manufacture of medicinal cannabis.

The GMP Licence has been granted by the Australian Therapeutic Goods Administration (TGA).

A GMP Licence is a mandatory requirement for the commercial manufacture of medicinal cannabis in Australia and is mutually recognised for supply of pharmaceutical goods in 29 countries across Europe, Asia and Canada.

“A rarity in the cannabis world”
THC chief executive officer Ken Charteris said: “THC Global has now received a pharmaceutical GMP licence issued by a government authority, which remains a rarity in the cannabis world.

“We anticipate near-term completions of commercial negotiations with multiple parties interested in our scalability, quality of production and ability to compete on price globally.”

One of the worlds largest cannabis facilities
The GMP Licence authorises THC to ma..

THC Global Group Ltd (ASX:THC) has secured a licence to manufacture therapeutic goods at its Southport Facility, completing all licenses required to commence commercial manufacture of medicinal cannabis.

The GMP Licence has been granted by the Australian Therapeutic Goods Administration (TGA).

A GMP Licence is a mandatory requirement for the commercial manufacture of medicinal cannabis in Australia and is mutually recognised for supply of pharmaceutical goods in 29 countries across Europe, Asia and Canada.

“A rarity in the cannabis world”

THC chief executive officer Ken Charteris said: “THC Global has now received a pharmaceutical GMP licence issued by a government authority, which remains a rarity in the cannabis world.

“We anticipate near-term completions of commercial negotiations with multiple parties interested in our scalability, quality of production and ability to compete on price globally.”

One of the worlds largest cannabis facilities

The GMP Licence authorises THC to manufacture active pharmaceutical ingredient (API) extracts; formulation and packaging of medicines; on-site testing and analysis; and supply of medicinal cannabis for human trials in Australia and globally.

THCs Southport Facility is the largest pharmaceutical bio-floral extraction facility in the Southern Hemisphere and is one of the worlds largest pharmaceutical GMP licenced facilities for the manufacture of medicinal cannabis.

With the receipt of the GMP Licence, THC will now seek to complete negotiations for the export supply of cannabis medicines.

The European design and equipment origin of the Southport facility meets key requirements for entering the rapidly expanding European market, differentiating THC from almost all established cannabis companies internationally.

Australian grown cannabis to be used

On January 2 2020, the Office of Drug Control clarified that appropriately licensed and permitted orRead More – Source

Continue Reading

Australia

Great Western Exploration appoints executive chairman

Great Western Exploration Limited ASX:GTE) has appointed current non-executive chairman Kevin Somes to the position of executive chairman effective immediately.

Somes has agreed to assume the role as executive chairman with no increase to his non-executive remuneration package of $55,000 per annum plus superannuation.

Other appointments[hhmc]
Jordan Luckett has stepped down as managing director for personal reasons but will continue to provide support in his new role as technical direRead More – Source

[contf]
[contfnew]

Proactiveinvestors
[contfnewc]
[contfnewc]

Great Western Exploration Limited ASX:GTE) has appointed current non-executive chairman Kevin Somes to the position of executive chairman effective immediately.

Somes has agreed to assume the role as executive chairman with no increase to his non-executive remuneration package of $55,000 per annum plus superannuation.

Other appointments


Jordan Luckett has stepped down as managing director for personal reasons but will continue to provide support in his new role as technical direRead More – Source

Continue Reading

Australia

Pure Minerals receives coverage from Independent Investment Research

Pure Minerals Ltd (ASX:PM1) has received research coverage from Independent Investment Research (IIR).

The 22-page report goes into detail regarding the proposed Townsville Energy Chemical Hub (TECH) Project in Queensland.

The report notes the building blocks are coming together quickly for the TECH Project with the pre-feasibility study (PFS) completed in December 2019 as well as the recently completed high purity alumina (HPA) scoping study.

Share price at deep discount to project's estimated NPV[hhmc]
Using a share price of 1.9 cents, the company has a market capitalisation of $16.1 million.

While the report does not designate a share price target, it does estimate a net present valuation (NPV) for the proposed TECH Project of between $47 million and $585 million.

The research firm does note the valuation relies on a number of factors including PFS assumptions and project approvals.

The following is an extract from the report:

VALUATION VERY SENSITIVE, BUT PRICE TREND PO..

Pure Minerals Ltd (ASX:PM1) has received research coverage from Independent Investment Research (IIR).

The 22-page report goes into detail regarding the proposed Townsville Energy Chemical Hub (TECH) Project in Queensland.

The report notes the building blocks are coming together quickly for the TECH Project with the pre-feasibility study (PFS) completed in December 2019 as well as the recently completed high purity alumina (HPA) scoping study.

Share price at deep discount to project's estimated NPV


Using a share price of 1.9 cents, the company has a market capitalisation of $16.1 million.

While the report does not designate a share price target, it does estimate a net present valuation (NPV) for the proposed TECH Project of between $47 million and $585 million.

The research firm does note the valuation relies on a number of factors including PFS assumptions and project approvals.

The following is an extract from the report:

VALUATION VERY SENSITIVE, BUT PRICE TREND POSITIVE

If we include the deferred consideration shares, Pure Minerals at A$0.019/sh would have a market capitalization of A$16.1M. Our NPV for the NiCo plant ranges from A$47M using the cycle price lows of the last three years to A$585M using cycle price highs over the last three years, and A$241M assuming current spot prices flat in real terms forever. The HPA bolt-on is additional value. These valuations are for the project only, and take no account of the cost of corporate overheads, nor of financing diRead More – Source

Continue Reading

Australia

Pure Minerals gains new substantial holder in managing director John Downie

Pure Minerals Ltd (ASX:PM1) has gained a new substantial holder in managing director John Downie.

Downie now holds 40.78 million shares increasing his stake in the company to 6.83%.

High-purity alumina (HPA) scoping study adds value[hhmc]
Pure recently received results for a scoping study evaluating the production of high-purity alumina (HPA) from its Townsville Energy Chemicals Hub (TECH) Project in Queensland.

The scoping study assessed the production of 4N HPA on a standalone basis, using the aluminium hydroxide as a feedstock.

This scoping study followed the December 2019 pre-feasibility study (PFS) on the TECH Project which identified the production of HPA as a key value-add opportunity for the project.

A 25-year operation producing 4,007 tonnes per annum (tpa) of 4N HPARead More – Source

[contf]
[contfnew]

Proactiveinvestors
[contfnewc]
[contfnewc]

Pure Minerals Ltd (ASX:PM1) has gained a new substantial holder in managing director John Downie.

Downie now holds 40.78 million shares increasing his stake in the company to 6.83%.

High-purity alumina (HPA) scoping study adds value


Pure recently received results for a scoping study evaluating the production of high-purity alumina (HPA) from its Townsville Energy Chemicals Hub (TECH) Project in Queensland.

The scoping study assessed the production of 4N HPA on a standalone basis, using the aluminium hydroxide as a feedstock.

This scoping study followed the December 2019 pre-feasibility study (PFS) on the TECH Project which identified the production of HPA as a key value-add opportunity for the project.

A 25-year operation producing 4,007 tonnes per annum (tpa) of 4N HPARead More – Source

Continue Reading

Trending